23 September 2019 - Deborah Wilkes
Archived
Advisers to the US Food and Drug Administration (FDA) have recommended that GlaxoSmithKline (GSK) Consumer Healthcare's nicotine oral spray can be marketed as an OTC product.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.